Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
Clinical trial NCT00650923 · COMPLETED
Trial details
- NCT number
- NCT00650923
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2013-06-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.